Physician profile
Gary Katz
NPI 1760444343
$71,094.52
in general payments reported to CMS, 2019-2025
29 companies · $6,589 in 2025
The $6,589 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $9,303 · 2021: $12K · 2022: $10K · 2023: $9,881 · 2024: $12K · 2025: $6,589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $24K · Food and Beverage: $3,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $24,460.12 |
| Food and Beverage | $3,632.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biopro, INC. | $66,262.48 | 2019-2025 | Tendon Anchor System, Tas, Subtalar |
| Orthofix Medical, INC. | $1,108.07 | 2020-2025 | Physio-Stim, Spinal-Stim, Truelok System |
| Horizon Therapeutics Plc | $681.57 | 2019-2023 | Krystexxa |
| Organogenesis INC. | $540.03 | 2021-2025 | Puraply Wound Matrix, Puraply Antimicrobial, Puraply |
| Smith+Nephew, INC. | $292.47 | 2019-2023 | Integra Movement Great Toe System, Integra, Memofix Super Elastic Nitinol Staple System |
| Stryker Corporation | $286.26 | 2021-2024 | Actishield |
| Inari Medical, INC. | $182.95 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Paratek Pharmaceuticals, INC. | $153.06 | 2023-2024 | Nuzyra |
| Crossroads Extremity Systems, LLC | $145.81 | 2020 | |
| Convatec INC. | $138.41 | 2023 | |
| Linvatec Corporation | $137.56 | 2024 | Biobrace 23mm |
| Boston Scientific Corporation | $134.60 | 2021-2025 | Eluvia |
| Globus Medical, INC. | $128.23 | 2025 | Senza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $124.56 | 2023 | Jublia |
| Nevro Corp. | $119.70 | 2022-2023 | Senza |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $109.10 | 2024 | |
| Merck Sharp & Dohme LLC | $108.97 | 2019 | |
| Djo, LLC | $99.30 | 2019 | |
| Wright Medical Technology, INC. | $79.21 | 2019 | |
| Medela LLC | $52.29 | 2020 | |
| Depuy Synthes Sales INC. | $44.50 | 2025 | Motoband |
| Mimedx Group, INC. | $36.10 | 2024-2025 | |
| Mvp Orthopedics INC | $30.73 | 2021 | |
| Treace Medical Concepts, INC. | $20.04 | 2023 | |
| Acumed LLC | $19.39 | 2025 | Acumed, Osteomed |
| Averitas Pharma INC. | $18.67 | 2024 | Qutenza |
| Orpyx Medical Technologies US INC. | $13.83 | 2023 | Orpyx Si |
| Heron Therapeutics, INC. | $13.34 | 2022 | |
| Ermi LLC | $13.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.